398 related articles for article (PubMed ID: 31907722)
1. Complications and 5-year survival after radical resections which include urological organs for locally advanced and recurrent pelvic malignancies: analysis of 646 consecutive cases.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Murphy DG; Heriot AG; Frizelle FA; McCormick JJ
Tech Coloproctol; 2020 Feb; 24(2):181-190. PubMed ID: 31907722
[TBL] [Abstract][Full Text] [Related]
2. Complications After Extended Radical Resections for Locally Advanced and Recurrent Pelvic Malignancies: A 25-Year Experience.
Peacock O; Waters PS; Kong JC; Warrier SK; Wakeman C; Eglinton T; Heriot AG; Frizelle FA; McCormick JJ
Ann Surg Oncol; 2020 Feb; 27(2):409-414. PubMed ID: 31520213
[TBL] [Abstract][Full Text] [Related]
3. Predictors of overall survival following extended radical resections for locally advanced and recurrent pelvic malignancies.
Kong JC; Peacock O; Waters PS; Eglinton T; Warrier SK; Wakeman C; Frizelle FA; Heriot AG; McCormick JJ
Langenbecks Arch Surg; 2020 Jun; 405(4):491-502. PubMed ID: 32533361
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of extended radical resections for locally advanced and recurrent pelvic malignancy involving the aortoiliac axis.
Peacock O; Smith N; Waters PS; Cheung F; McCormick JJ; Warrier SK; Wagner T; Heriot AG
Colorectal Dis; 2020 Jul; 22(7):818-823. PubMed ID: 31961476
[TBL] [Abstract][Full Text] [Related]
5. Total Pelvic Exenteration for Locally Advanced and Recurrent Rectal Cancer: Urological Outcomes and Adverse Events.
Khan O; Patsouras D; Ravindraanandan M; Abrar MM; Schizas A; George M; Malde S; Thurairaja R; Khan MS; Sahai A
Eur Urol Focus; 2021 May; 7(3):638-643. PubMed ID: 32622667
[TBL] [Abstract][Full Text] [Related]
6. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
7. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
8. Urological outcomes following pelvic exenteration for advanced pelvic cancer are not inferior to those following radical cystectomy.
Aslim EJ; Chew MH; Chew GK; Lee LS
ANZ J Surg; 2018 Sep; 88(9):896-900. PubMed ID: 29895098
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Impact of Intra-abdominal/Pelvic Inflammation After Radical Surgery for Locally Recurrent Rectal Cancer.
Tanaka M; Kanemitsu Y; Shida D; Ochiai H; Tsukamoto S; Nagino M; Moriya Y
Dis Colon Rectum; 2017 Aug; 60(8):827-836. PubMed ID: 28682968
[TBL] [Abstract][Full Text] [Related]
10. [Analysis on risk factors of the degree of radical resection and prognosis of patients with locally recurrent rectal cancer].
Zhang JL; Wu T; Chen GW; Wang PY; Jiang Y; Tang JQ; Wu YC; Pan YS; Liu YC; Wan YL; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):472-479. PubMed ID: 32842427
[No Abstract] [Full Text] [Related]
11. Outcomes of urinary diversion after surgery for locally advanced or locally recurrent rectal cancer with complete cystectomy; ileal and colon conduit.
Hagemans JAW; Voogt ELK; Rothbarth J; Nieuwenhuijzen GAP; Kirkels WJ; Boormans JL; Koldewijn EL; Richardson R; Verhoef C; Rutten HJT; Burger JWA
Eur J Surg Oncol; 2020 Jun; 46(6):1160-1166. PubMed ID: 32122756
[TBL] [Abstract][Full Text] [Related]
12. Role of pelvic exenteration in the management of locally advanced primary and recurrent rectal cancer.
Xin KY; Ng DW; Tan GH; Teo MC
J Gastrointest Cancer; 2014 Sep; 45(3):291-7. PubMed ID: 24563189
[TBL] [Abstract][Full Text] [Related]
13. Sacral resection with pelvic exenteration for advanced primary and recurrent pelvic cancer: a single-institution experience of 100 sacrectomies.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD; Austin KK
Dis Colon Rectum; 2014 Oct; 57(10):1153-61. PubMed ID: 25203370
[TBL] [Abstract][Full Text] [Related]
14. Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
Brown KG; Solomon MJ; Latif ER; Koh CE; Vasilaras A; Eisinger D; Sved P
J Surg Oncol; 2017 Mar; 115(3):307-311. PubMed ID: 27859276
[TBL] [Abstract][Full Text] [Related]
15. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
17. Assessing the impact of a sacral resection on morbidity and survival after extended radical surgery for locally recurrent rectal cancer.
Milne T; Solomon MJ; Lee P; Young JM; Stalley P; Harrison JD
Ann Surg; 2013 Dec; 258(6):1007-13. PubMed ID: 23364701
[TBL] [Abstract][Full Text] [Related]
18. Urinary diversion after total pelvic exenteration for rectal cancer.
Russo P; Ravindran B; Katz J; Paty P; Guillem J; Cohen AM
Ann Surg Oncol; 1999 Dec; 6(8):732-8. PubMed ID: 10622500
[TBL] [Abstract][Full Text] [Related]
19. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
20. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
